এই এপিসোড সম্বন্ধে

ইংরেজি
মার্কিন যুক্তরাষ্ট্র

প্রতিলিপি 🔗

অতীতের এপিসোডগুলি অনুসন্ধান করুন

The Harry Glorikian Show এর অতীতের এপিসোডগুলি অনুসন্ধান করুন।

এই পডকাস্টের অন্যান্য পর্বগুলি৷

How ConcertAI Came to Lead in Cancer Data

If you look back at all the health-tech and drug development companies Harry has hosted on the show, an interesting pattern starts to emerge: a very large number of those companies have gone on to enormous growth and success in their markets. It could be that being on the podcast is like a catapult…
Investors and companies in the life science industry have been betting a lot of money over the last few years on a single idea: that computation will help us get a lot better at developing new drugs. But the word “computation” covers a pretty broad range of techniques. And the reason that there are…

T Cell Engagers: The New Cancer Drug?

One of the most amazing successes in the battle against cancer over the last two decades has been the introduction of antibody drugs that harness the body’s own immune system to kill tumor cells. Finding those drugs may sound like a biology problem rather than a machine learning or a big-data probl…
If you learned that radiologists looking at CT scans for the traditional signs of coronary artery disease catch only 20 percent of the people who actually have a high risk of a heart attack, and if you learned that there’s a new AI-based test that can catch subtle signs of inflammation in the other…
দাবি পরিত্যাগ: এই পৃষ্ঠায় এম্বেড করা পডকাস্ট এবং আর্টওয়ার্ক Harry Glorikian থেকে এসেছে, যা এর মালিকের সম্পত্তি এবং Listen Notes, Inc দ্বারা অনুমোদিত বা অনুমোদিত নয়৷